Skip to content

Clinical trials

Observational Hemophilia B trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia B Phase: Observational Clear all

103 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20061
20073
20083
20094
20103
20112
20121
20134
20146
20155
20166
201710
20189
20196
20207
20217
20225
20236
20245
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed61
Unknown status13
Recruiting10
Terminated6
Enrolling by invitation5
Active, not recruiting3
Not yet recruiting3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S17
Pfizer8
Swedish Orphan Biovitrum6
Baxalta now part of Shire5
Wyeth is now a wholly owned subsidiary of Pfizer5
American Thrombosis and Hemostasis Network4
CSL Behring4
Hasan Kalyoncu University3
Assistance Publique - Hôpitaux de Paris2
Cliniques universitaires Saint-Luc- Université Catholique de Louvain2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia B103
Hemophilia A72
Anemia, Sickle Cell6
Hematologic Diseases6
von Willebrand Diseases6
Blood Coagulation Disorders5
Coagulation Protein Disorders4
Cystic Fibrosis4
Genetic Diseases, Inborn4
Hemorrhagic Disorders4

Trials

Showing 76 to 100 of 103. Each trial links to its page on Pharma Observatory.

3 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.